Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy

NCT01664663 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

37

Enrollment

NETWORK

Sponsor class

Stopped Safety analysis showed increased grade 5 toxicity in experimental arm.

Conditions

Non Small Cell Lung Cancer
Locally Advanced Disease

Interventions

RADIATION: Standard radiochemotherapy to 68 Gy
RADIATION: Dose escalated radiochemotherapy up to 84 Gy

Sponsor

Ass. Prof. Jan Nyman